China SXT Pharmaceuticals Balance Sheet (2017-2026)

Reported Financials

China SXT Pharmaceuticals Quarterly Balance Sheet

Periods 19 quarters

Latest Mar 2026

China SXT Pharmaceuticals reported total assets of $34.75M and total liabilities of $5.05M for the quarter ended Mar 2026, up 50.3% year over year. This balance sheet covers 19 quarters of results from Dec 2017 through Mar 2026, standardized by Business Quant from the company’s SEC filings.

Balance Sheet	Dec2017	Mar2018	Sep2018	Dec2018	Mar2019	Sep2019	Mar2020	Sep2020	Mar2021	Sep2021	Mar2022	Sep2022	Mar2023	Sep2023	Mar2024	Sep2024	Mar2025	Sep2025	Mar2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv.	0.01M	0.66M	0.38M	0.66M	9.29M	9.29M	7.29M	10.35M	13.36M	0.03M	13.36M	15.57M	17.37M	17.37M	12.08M	18.51M	18.10M	21.17M	28.18M
Short-term InvestmentsInvestments (Current)		0.10M	0.18M		0.16M	0.08M			0.03M		0.05M				0.01M		0.03M	0.03M	368.00
Cash & Current Investments	0.01M	0.76M	0.57M	0.66M	9.45M	9.37M	7.29M	10.35M	13.38M	0.03M	13.40M	15.57M	17.37M	17.37M	12.08M	18.51M	18.13M	21.20M	28.18M
Receivables - NetNet Receivables		2.60M	3.89M		4.25M	4.63M	3.92M	5.69M	4.78M	4.16M	4.10M	4.00M	2.87M	2.77M	3.05M	3.45M	3.38M	3.35M	2.87M
Receivables - OtherOther Receivables	0.57M	0.94M	0.11M	0.94M	0.13M	3.50M	-3.59M	1.19M	0.88M	2.98M	0.34M	2.75M	0.03M		0.03M	1.10M		1.36M	15.85M
Receivables		3.54M	3.99M		4.37M	8.13M	0.33M	6.88M	5.66M	7.14M	4.44M	6.75M	2.90M	2.77M	3.07M	4.55M	3.38M	4.71M	18.72M
Raw Materials									0.35M	0.34M	0.60M	0.19M	0.24M		0.32M	0.35M	0.44M	0.30M	0.28M
Finished Goods									0.62M	0.62M	0.58M	0.59M	0.45M		0.55M	0.60M	0.45M	0.51M	0.64M
Inventory		1.27M	1.07M		1.01M	0.85M	0.89M	0.87M	0.86M	0.84M	1.02M	0.63M	0.53M	0.49M	0.79M	0.87M	0.83M	0.75M	0.78M
Current Deferred Tax AssetsCurrent Deferred Tax							0.05M
Prepaid Assets		0.91M	0.73M		707.34M	2.02M	4.62M	2,174.23M	1.86M	1,816.64M	0.86M	1,040.04M	0.23M	137.98M	0.03M	0.22M	0.03M	0.31M	0.09M
Current Assets		6.10M	6.55M		15.59M	17.54M	19.64M	22.06M	23.23M	11.66M	22.45M	12.36M	19.52M	13.50M	14.23M	21.99M	21.30M	26.04M	34.51M
Non-Current Assets
Construction in Progress		0.63M	0.57M		0.65M	0.18M	0.33M	0.45M	0.36M	0.36M	0.36M	0.34M	0.35M
Property, Plant & Equipment (Net)PP&E (Net)		0.86M	0.78M		1.16M	1.76M	1.57M	1.46M	1.43M	1.30M	1.23M	1.01M	0.96M	0.81M	0.33M	0.23M	0.18M	0.15M	0.12M
Long-Term Investments						3.50M	1.57M	1.61M	1.58M	1.58M	1.58M	1.58M
Intangibles		0.06M	0.05M		0.06M	0.05M	0.05M	0.05M	0.08M	0.04M	0.04M	0.03M	0.03M	0.02M	0.02M	0.02M	0.01M	0.01M	0.01M
Goodwill & Intangibles		0.06M	0.05M		0.06M	0.05M	0.05M	0.05M	0.08M	0.04M	0.04M	0.03M	0.03M	0.02M	0.02M	0.02M	0.01M	0.01M	0.01M
Long-Term Deferred Tax		0.01M			0.01M	0.01M	0.11M	0.02M	0.32M		0.39M	0.56M	0.55M	0.65M
Other Non-Current Assets			0.05M		0.00M	-3.61M	0.51M	2.86M	-8.85M	9.31M	9.46M	8.43M	8.74M		8.31M	8.55M	0.37M		0.24M
Non-Current Assets		1.56M	1.45M		1.88M	5.50M	2.07M	1.98M	11.31M	11.01M	11.09M	9.82M	10.03M	1.09M	8.89M	9.01M	0.37M	0.31M	0.24M
Assets		7.66M	7.95M		17.47M	23.05M	21.70M	24.04M	34.55M	22.67M	33.55M	22.18M	29.55M	14.59M	23.13M	31.00M	21.66M	26.35M	34.75M
Liabilities
Current Liabilities
Accounts Payables		2.41M	2.00M		1.69M	1.96M	1.94M	1.36M	3.05M	1.49M	1.48M	1.56M	1.38M	1.32M	1.28M	1.66M	1.16M	0.53M	0.50M
Notes Payables		0.39M	0.21M		2.48M	1.83M	0.04M	1.50M	12.15M	2.12M	8.70M		0.17M	0.27M	0.49M	0.70M		0.98M
Payables		2.79M	2.20M		4.17M	3.79M	1.99M	2.86M	15.20M	3.61M	10.18M	1.56M	1.55M	1.58M	1.77M	2.36M	1.16M	1.51M	0.50M
Accumulated Expenses		0.42M	0.31M		0.69M	0.70M	2.24M	2.46M	3.05M	3.36M	3.53M	3.28M	3.14M	3.25M	2.77M	2.92M	2.17M	3.27M	2.63M
Other Accumulated Expenses		0.15M			0.16M	0.17M	0.29M	0.73M	0.82M	0.91M	1.16M	1.03M	0.79M	0.97M	0.36M	0.46M	0.06M	0.92M	0.07M
Short term Debt					0.03M	4.94M	6.64M	0.05M	0.04M	0.02M	2.03M	1.21M	3.16M	2.50M	1.78M	0.70M	0.70M	0.00M	0.36M
Current Leases					1.53M		8.31M						0.06M	0.06M	0.06M	0.03M	0.06M	0.06M	0.07M
Current Taxes		0.87M	1.16M		1.06M	1.03M	0.99M	1.32M	1.16M	1.18M	1.17M	1.07M	1.10M	1.04M	1.05M	1.09M	1.04M	1.04M	0.00M
Current Deferred Revenue		0.29M	0.12M		0.06M	0.12M	0.30M	0.22M	0.26M	0.22M	0.08M	0.07M	0.17M	0.19M	0.19M	0.19M	0.06M	0.07M	0.10M
Total Current Liabilities		4.37M	3.99M		6.32M	10.76M	12.26M	5.51M	18.58M	8.88M	17.12M	7.29M	14.50M	9.20M	8.90M	15.66M	6.01M	5.96M	4.35M
Non-Current Liabilities
Non-Current Debt			0.19M		0.04M	0.06M	0.04M	0.02M	0.01M		1.12M		0.12M	0.11M	0.12M	0.12M	0.10M	0.07M	0.64M
Convertible Debt						0.82M
Operating Leases													0.25M	0.20M	0.18M	0.18M	0.12M	0.09M	0.05M
Other Non-Current Liabilities					0.08M	0.07M	0.11M	0.10M	0.47M	0.48M	0.12M	0.11M	0.11M	0.15M	0.21M	0.22M	0.05M	0.02M	0.02M
Total Non-Current Liabilities					0.04M	0.87M	0.04M	0.02M	0.01M	8.40M	17.00M	7.18M	0.37M	0.31M	0.29M	0.30M	29.98M	0.16M	25.18M
Total Liabilities		4.37M	3.35M		6.36M	11.64M	12.30M	5.52M	18.59M	8.88M	17.12M	7.29M	14.86M	9.51M	9.20M	15.96M	6.22M	6.12M	5.05M
Shareholder's Equity
Total Debt		0.39M	0.40M		2.55M	6.83M	6.72M	1.56M	12.19M	2.14M	11.85M	1.21M	3.44M	2.87M	2.39M	1.52M	0.80M	1.05M	1.00M
Common Equity		3.29M	4.60M		11.11M	11.41M	9.40M	18.52M	15.96M	13.79M	16.08M	14.55M	14.69M	5.08M	13.93M	15.03M	15.44M	20.23M	29.71M
Liabilities and Shareholders Equity		7.66M	7.95M		17.47M	23.05M	21.70M	24.04M	34.55M	22.67M	33.55M	22.18M	29.55M	14.59M	23.13M	31.00M	21.66M	26.35M	34.75M
Retained Earnings		1.46M	1.46M		7.95M	11.41M	17.16M	24.23M	25.32M	26.01M	30.99M	32.56M	35.59M	35.95M	-24.71M	33.39M	-28.02M	-34.38M	-34.22M

China SXT Pharmaceuticals SXTC Balance Sheet (2017-2026)

China SXT Pharmaceuticals Quarterly Balance Sheet

Create an account

Sign In

Reset Password